J.C. Sabourin

884 total citations
16 papers, 546 citations indexed

About

J.C. Sabourin is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, J.C. Sabourin has authored 16 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in J.C. Sabourin's work include Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). J.C. Sabourin is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). J.C. Sabourin collaborates with scholars based in France, Belgium and Greece. J.C. Sabourin's co-authors include Agnès François, Fabien Milliat, Jean Bourhis, Horace Roman, Nicolas Bourdel, L. Marpeau, Marie-Josée Terrier-Lacombe, R Barnoud, Dominique Pasquier and Christiane Bailly and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and American Journal Of Pathology.

In The Last Decade

J.C. Sabourin

15 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.C. Sabourin France 10 169 137 126 126 118 16 546
Daniel Schultz United States 15 250 1.5× 93 0.7× 50 0.4× 79 0.6× 55 0.5× 30 507
Ioannis Efstratiou Greece 12 108 0.6× 188 1.4× 165 1.3× 68 0.5× 66 0.6× 44 605
Ömür Ataoğlu Türkiye 16 196 1.2× 147 1.1× 153 1.2× 90 0.7× 26 0.2× 70 677
S. Rogers United Kingdom 12 91 0.5× 236 1.7× 111 0.9× 62 0.5× 44 0.4× 17 607
Serap Akyürek Türkiye 12 194 1.1× 135 1.0× 69 0.5× 29 0.2× 145 1.2× 50 623
Tomoko Wakasa Japan 16 157 0.9× 207 1.5× 141 1.1× 83 0.7× 27 0.2× 85 767
Timothy J. Pelkey United States 8 82 0.5× 121 0.9× 80 0.6× 92 0.7× 19 0.2× 9 378
Mette Winderen Lindegaard Norway 8 111 0.7× 109 0.8× 22 0.2× 87 0.7× 73 0.6× 16 419
Kung‐Chu Ho Taiwan 17 145 0.9× 132 1.0× 50 0.4× 267 2.1× 493 4.2× 36 971
Ronny Kalash United States 13 183 1.1× 122 0.9× 103 0.8× 17 0.1× 139 1.2× 36 506

Countries citing papers authored by J.C. Sabourin

Since Specialization
Citations

This map shows the geographic impact of J.C. Sabourin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C. Sabourin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C. Sabourin more than expected).

Fields of papers citing papers by J.C. Sabourin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.C. Sabourin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C. Sabourin. The network helps show where J.C. Sabourin may publish in the future.

Co-authorship network of co-authors of J.C. Sabourin

This figure shows the co-authorship network connecting the top 25 collaborators of J.C. Sabourin. A scholar is included among the top collaborators of J.C. Sabourin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.C. Sabourin. J.C. Sabourin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tarlet, Georges, Olivier Guipaud, J.C. Sabourin, et al.. (2017). Endothelial Hey2 deletion reduces endothelial-to-mesenchymal transition and mitigates radiation proctitis in mice. Scientific Reports. 7(1). 4933–4933. 23 indexed citations
2.
Mahjoubi, Linda, et al.. (2016). Incidence of Lung Adenocarcinoma Biomarker in a Caribbean and African Caribbean Population. Journal of Thoracic Oncology. 11(5). 769–773. 10 indexed citations
3.
Lièvre, Astrid, J.L. Merlin, Pierre Laurent‐Puig, et al.. (2015). 420 Flash RAS study: RAS testing assessment in patients with metastatic colorectal cancer in 2014. European Journal of Cancer. 51. S85–S85.
4.
Ilié, Marius, Sandra Lassalle, Élodie Long-Mira, et al.. (2014). Diagnostic Value of Immunohistochemistry for the Detection of the BRAF V600E Mutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA-Based Assays. Thyroid. 24(5). 858–866. 51 indexed citations
5.
Sefrioui, David, Richard Sesboüé, Frédéric Blanchard, et al.. (2014). Clinical Interest of Digital Pcr for Routine Detection of Circulating Dna in Metastatic Colorectal Cancer. Annals of Oncology. 25. iv559–iv559. 2 indexed citations
6.
7.
Fiore, Frédéric Di, A. Lamy, Frédéric Blanchard, et al.. (2011). TP53 mutations in irinotecan-refractory KRAS wt-BRAF wt metastatic colorectal cancer patients treated with cetuximab-based chemotherapy.. Journal of Clinical Oncology. 29(4_suppl). 426–426. 5 indexed citations
8.
9.
10.
Bibeau, Frédéric, Frédéric Di Fiore, Simon Thézenas, et al.. (2008). Association of FcγRIIa and FcγRIIa polymorphisms with clinical outcome in metastatic colorectal cancer patients (mCRC) treated with cetuximab and irinotecan. Journal of Clinical Oncology. 26(15_suppl). 11004–11004. 18 indexed citations
11.
Fiore, Frédéric Di, Florence Le Pessot, A. Lamy, et al.. (2007). KRAS mutation is highly predictive of cetuximab resistance in metastatic colorectal cancer. Journal of Clinical Oncology. 25(18_suppl). 10502–10502. 6 indexed citations
12.
Milliat, Fabien, Agnès François, Éric Deutsch, et al.. (2006). Influence of Endothelial Cells on Vascular Smooth Muscle Cells Phenotype after Irradiation. American Journal Of Pathology. 169(4). 1484–1495. 109 indexed citations
13.
Vozenin, Marie‐Catherine, Fabien Milliat, J.C. Sabourin, et al.. (2003). Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression. International Journal of Radiation Oncology*Biology*Physics. 56(2). 561–572. 84 indexed citations
14.
Barnoud, R, J.C. Sabourin, Dominique Pasquier, et al.. (2000). Immunohistochemical Expression of WT1 by Desmoplastic Small Round Cell Tumor. The American Journal of Surgical Pathology. 24(6). 830–836. 97 indexed citations
15.
Morice, Philippe, Aurélie Fabre, P. Pautier, et al.. (2000). Krukenberg tumor: a clinico-pathological study of 15 cases.. PubMed. 20(3). 202–6. 20 indexed citations
16.
Sabourin, J.C., Janine Wechsler, M. Bagot, & Élie Serge Zafrani. (1993). [Follicular mucinosis. A dermatologic disorder frequently associated with T-cell lymphoma].. PubMed. 13(1). 29–31. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Schultz Breakdown of academic impact, for papers by Ioannis Efstratiou Breakdown of academic impact, for papers by Ömür Ataoğlu Breakdown of academic impact, for papers by S. Rogers Breakdown of academic impact, for papers by Serap Akyürek Breakdown of academic impact, for papers by Tomoko Wakasa Breakdown of academic impact, for papers by Timothy J. Pelkey Breakdown of academic impact, for papers by Mette Winderen Lindegaard Breakdown of academic impact, for papers by Kung‐Chu Ho Breakdown of academic impact, for papers by Ronny Kalash
Rankless by CCL
2026